31 Mar 2024
Assets34.65
Total Income24.37
EBITDA4.08
Profit After Tax2.14
NET Worth6.21
Reserves and Surplus2.93
Total Borrowing15.13
At a glance
Updated 2026-09-09The shares listed at ₹395.20, a 90.00% move from the issue price. Avience Biomedicals is a SME IPO with an issue size of ₹30.24 crore, proposed for listing on NSE SME. The offer opens on 18th Jun 2026 and closes on 22nd Jun 2026. The issue structure includes a fresh issue of ₹28.53 crore. The current listing schedule points to 25th Jun 2026.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹30.24 Cr
Fresh issue₹28.53 Cr
Face value₹10
Price band₹196.00–₹208.00
Allotment23rd Jun 2026
Listing25th Jun 2026
Listing performance
Full performance ↗Issue price₹208.00
Listing price₹395.20
Current price—
Listing gain90.00%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹145.00
GMP / upper price69.71%
Est. listing₹353.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens18th Jun 2026
Closes22nd Jun 2026
Allotment23rd Jun 2026
Refund24th Jun 2026
Demat24th Jun 2026
Listing25th Jun 2026
Subscription demand
Full bidding ↗QIB196.77×
sHNI451.35×
bHNI420.38×
NII / HNI420.38×
Retail401.36×
Total385.32×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1200 | ₹249,600 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh | ₹14.05 Cr |
| Funding the working capital requirements of the Company | ₹8.25 Cr |
| General Corporate Purposes | ₹3.97 Cr |
| Public Issue Expenses | ₹3.97 Cr |
| Total | ₹30.24 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue41.94₹ Cr · -8.8% vs prior year
EBITDA10.34₹ Cr · -9.4% vs prior year
PAT5.74₹ Cr · -20.6% vs prior year
Assets66.07₹ Cr · +16.9% vs prior year
Net Worth28.52₹ Cr · +25.2% vs prior year
Borrowing26.73₹ Cr · +20.6% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2025
Assets56.52
Total Income45.97
EBITDA11.41
Profit After Tax7.23
NET Worth22.78
Reserves and Surplus18.75
Total Borrowing22.16
31 Jan 2026
Assets66.07
Total Income41.94
EBITDA10.34
Profit After Tax5.74
NET Worth28.52
Reserves and Surplus24.49
Total Borrowing26.73
KPIs
| KPI | Jan 31, 206 | Mar 31, 2025 |
|---|---|---|
| ROE | 22.38% | 50.14% |
| ROCE | 16.99% | 24.84% |
| Debt / Equity | 0.94% | 0.97% |
| RoNW | 22.38% | 49.89% |
| PAT Margin | 15.86% | |
| EBITDA Margin | 24.70% | 25.22% |
| Price to Book Value | 2.94 | 3.68 |
Valuation & shareholding
Pre-IPO EPS17.94
Post-IPO EPS12.56
Pre-IPO P/E11.59
Post-IPO P/E16.56
Promoter holding pre87.89%
Promoter holding post64.59%
Market cap₹114.09 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Avience Biomedicals Lmited IPO | — | 22.74 x | — | — |
| Abh Healthcare IPO | — | 20.69 x | — | — |
| Credent Connect IPO | — | 153.66 x | — | — |
| H. R. IPO | — | 17.53 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh | ₹14.05 Cr |
| Funding the working capital requirements of the Company | ₹8.25 Cr |
| General Corporate Purposes | ₹3.97 Cr |
| Public Issue Expenses | ₹3.97 Cr |
| Total | ₹30.24 Cr |
Registrar & lead managers
Registrar
Skyline Financial Services Pvt.Ltd.Lead managers
- Fintellectual Corporate Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-09.
IPO UPDATE ALERTS
Register for IPO Updates →Track Avience Biomedicals without missing an update
Register for subscription, GMP, allotment and listing notifications.